How to Cut US Drug Prices Without Hurting Innovation

Published on May 13, 2025

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the US; in Germany, it’s $328. The US price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000.

Continue reading on website
Other news

Buyout Firms Ramp Up Debt Deals to Pay Dividends

May 13, 2025
Companies are launching a number of debt deals designed to pay out a dividend to their private equity owners, at a time when buyout firms are under pressure to return money to clients.

Liquidity Risk in 2025: A Strategic Priority, Not a Side Concern

May 13, 2025
In 2025, liquidity is not a background variable — it's a front-line risk factor, one that’s being tested repeatedly as global markets navigate a web of geopolitical uncertainty and macroeconomic signals.